IN2012DN01954A - - Google Patents
Download PDFInfo
- Publication number
- IN2012DN01954A IN2012DN01954A IN1954DEN2012A IN2012DN01954A IN 2012DN01954 A IN2012DN01954 A IN 2012DN01954A IN 1954DEN2012 A IN1954DEN2012 A IN 1954DEN2012A IN 2012DN01954 A IN2012DN01954 A IN 2012DN01954A
- Authority
- IN
- India
- Prior art keywords
- partially processed
- amount
- bont
- unprocessed
- solution
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/5308—Immunoassay; Biospecific binding assay; Materials therefor for analytes not provided for elsewhere, e.g. nucleic acids, uric acid, worms, mites
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
- C07K16/1267—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-positive bacteria
- C07K16/1282—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-positive bacteria from Clostridium (G)
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56911—Bacteria
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/573—Immunoassay; Biospecific binding assay; Materials therefor for enzymes or isoenzymes
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/94—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving narcotics or drugs or pharmaceuticals, neurotransmitters or associated receptors
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
- C07K2317/34—Identification of a linear epitope shorter than 20 amino acid residues or of a conformational epitope defined by amino acid residues
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/195—Assays involving biological materials from specific organisms or of a specific nature from bacteria
- G01N2333/33—Assays involving biological materials from specific organisms or of a specific nature from bacteria from Clostridium (G)
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/90—Enzymes; Proenzymes
- G01N2333/914—Hydrolases (3)
- G01N2333/948—Hydrolases (3) acting on peptide bonds (3.4)
- G01N2333/95—Proteinases, i.e. endopeptidases (3.4.21-3.4.99)
- G01N2333/964—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue
- G01N2333/96402—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from non-mammals
- G01N2333/96405—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from non-mammals in general
- G01N2333/96408—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from non-mammals in general with EC number
- G01N2333/96419—Metalloendopeptidases (3.4.24)
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Chemical & Material Sciences (AREA)
- Molecular Biology (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Biomedical Technology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Analytical Chemistry (AREA)
- Biotechnology (AREA)
- Cell Biology (AREA)
- Pathology (AREA)
- Microbiology (AREA)
- General Physics & Mathematics (AREA)
- Food Science & Technology (AREA)
- Physics & Mathematics (AREA)
- Organic Chemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Tropical Medicine & Parasitology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Virology (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US27945309P | 2009-10-21 | 2009-10-21 | |
| EP09173612 | 2009-10-21 | ||
| PCT/EP2010/065618 WO2011048044A1 (en) | 2009-10-21 | 2010-10-18 | System for determining unprocessed and partially processed neurotoxin type a |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IN2012DN01954A true IN2012DN01954A (ko) | 2015-08-21 |
Family
ID=41466928
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IN1954DEN2012 IN2012DN01954A (ko) | 2009-10-21 | 2010-10-18 |
Country Status (16)
| Country | Link |
|---|---|
| US (2) | US8841080B2 (ko) |
| EP (1) | EP2491384B1 (ko) |
| JP (1) | JP5709877B2 (ko) |
| KR (1) | KR101788340B1 (ko) |
| CN (1) | CN102597769B (ko) |
| AU (1) | AU2010309932B2 (ko) |
| BR (1) | BR112012009436A2 (ko) |
| CA (1) | CA2773478C (ko) |
| ES (1) | ES2449303T3 (ko) |
| HK (1) | HK1173493A1 (ko) |
| IL (1) | IL218455A (ko) |
| IN (1) | IN2012DN01954A (ko) |
| MX (1) | MX2012004454A (ko) |
| PT (1) | PT2491384E (ko) |
| RU (1) | RU2545825C9 (ko) |
| WO (1) | WO2011048044A1 (ko) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2578250C (en) * | 2004-07-26 | 2013-03-05 | Merz Pharma Gmbh & Co. Kgaa | Therapeutic composition with a botulinum neurotoxin |
| RU2549463C1 (ru) * | 2013-12-03 | 2015-04-27 | Федеральное бюджетное учреждение науки Государственный научный центр прикладной микробиологии и биотехнологии (ФБУН ГНЦ ПМБ) | Способ определения ботулинического нейротоксина типа а на основе иммунодетекции, сопряженной с полимеразной цепной реакцией |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2340299A (en) | 1998-01-26 | 1999-08-09 | University Of Massachusetts | Biologically active hemagglutinin from type a (clostridium botulinum) and methods of use |
| US6667158B1 (en) | 1998-12-17 | 2003-12-23 | The United States Of America As Represented By The Secretary Of The Army | Antibodies against type a botulinum neurotoxin |
| CA2371279A1 (en) | 1999-05-12 | 2000-11-16 | Leonard A. Smith | Recombinant vaccine against botulinum neurotoxin |
| US20080171347A1 (en) * | 2003-04-11 | 2008-07-17 | Atassi M Zouhair | Determining and reducing immunoresistance to botulinum toxin therapy using botulinum toxin a peptides |
| FR2869908B1 (fr) * | 2004-05-05 | 2006-07-28 | Pharmaleads | Substrat peptidique reconnu par la toxine botulique de type a, bont/a et son utilisation pour detecter et/ou doser ladite toxine ou des inhibiteurs de son activite |
| CN100575363C (zh) * | 2007-03-07 | 2009-12-30 | 中国人民解放军军事医学科学院微生物流行病研究所 | 人源抗a型肉毒神经毒素基因工程抗体及其制备方法与用途 |
| US7732579B2 (en) * | 2007-06-13 | 2010-06-08 | The United States Of America As Represented By The Secretary Of Agriculture | High-affinity monoclonal antibodies for botulinum toxin type A |
| US9447175B2 (en) * | 2009-02-19 | 2016-09-20 | Merz Pharma Gmbh & Co. Kgaa | Means and methods for manufacturing highly pure neurotoxin |
| CN101503472B (zh) * | 2009-03-17 | 2011-08-10 | 中国人民解放军军事医学科学院生物工程研究所 | 抗a型肉毒毒素的人源性中和抗体及其应用 |
-
2010
- 2010-10-18 EP EP10765465.9A patent/EP2491384B1/en active Active
- 2010-10-18 RU RU2012120572/15A patent/RU2545825C9/ru active
- 2010-10-18 JP JP2012534647A patent/JP5709877B2/ja active Active
- 2010-10-18 US US13/503,128 patent/US8841080B2/en active Active
- 2010-10-18 WO PCT/EP2010/065618 patent/WO2011048044A1/en active Application Filing
- 2010-10-18 AU AU2010309932A patent/AU2010309932B2/en active Active
- 2010-10-18 KR KR1020127012793A patent/KR101788340B1/ko active IP Right Grant
- 2010-10-18 ES ES10765465.9T patent/ES2449303T3/es active Active
- 2010-10-18 MX MX2012004454A patent/MX2012004454A/es active IP Right Grant
- 2010-10-18 CA CA2773478A patent/CA2773478C/en active Active
- 2010-10-18 PT PT107654659T patent/PT2491384E/pt unknown
- 2010-10-18 BR BR112012009436A patent/BR112012009436A2/pt not_active Application Discontinuation
- 2010-10-18 IN IN1954DEN2012 patent/IN2012DN01954A/en unknown
- 2010-10-18 CN CN201080047556.6A patent/CN102597769B/zh active Active
-
2012
- 2012-03-04 IL IL218455A patent/IL218455A/en active IP Right Grant
-
2013
- 2013-01-15 HK HK13100603.4A patent/HK1173493A1/xx unknown
-
2014
- 2014-08-13 US US14/458,514 patent/US9213026B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| AU2010309932B2 (en) | 2015-04-16 |
| JP5709877B2 (ja) | 2015-04-30 |
| KR101788340B1 (ko) | 2017-10-19 |
| WO2011048044A1 (en) | 2011-04-28 |
| JP2013508701A (ja) | 2013-03-07 |
| RU2545825C2 (ru) | 2015-04-10 |
| MX2012004454A (es) | 2012-05-22 |
| BR112012009436A2 (pt) | 2017-02-21 |
| US9213026B2 (en) | 2015-12-15 |
| CN102597769B (zh) | 2014-11-05 |
| ES2449303T3 (es) | 2014-03-19 |
| CA2773478A1 (en) | 2011-04-28 |
| IL218455A (en) | 2015-10-29 |
| US20120214182A1 (en) | 2012-08-23 |
| US8841080B2 (en) | 2014-09-23 |
| PT2491384E (pt) | 2014-02-21 |
| AU2010309932A1 (en) | 2012-04-05 |
| EP2491384B1 (en) | 2013-12-04 |
| US20140349322A1 (en) | 2014-11-27 |
| RU2545825C9 (ru) | 2015-06-20 |
| KR20120102639A (ko) | 2012-09-18 |
| HK1173493A1 (en) | 2013-05-16 |
| EP2491384A1 (en) | 2012-08-29 |
| CA2773478C (en) | 2018-07-17 |
| RU2012120572A (ru) | 2013-11-27 |
| IL218455A0 (en) | 2012-04-30 |
| CN102597769A (zh) | 2012-07-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX360513B (es) | Medios y metodos para la determinacion de la actividad biologica de polipeptidos de neurotoxina en celulas. | |
| UA95958C2 (en) | Antibody that binds to cd22, immunoconjugates and uses therefor | |
| MX2011011045A (es) | Medios y metodos para determinacion de cantidad de polipeptido de neurotoxina y de sus actividades cataliticas y proteoliticas. | |
| WO2008081849A1 (ja) | ペプチドおよびタンパク質定量法 | |
| NZ609824A (en) | Immunochromatography devices, methods and kits | |
| WO2008134526A3 (en) | Glycoprotein profiling of bladder cancer | |
| WO2010091182A3 (en) | Methods for screening candidate agents for modulating prorenin and renin, assays for detecting prorenin, and antibodies used therein | |
| WO2012035296A3 (en) | Assay for prions | |
| EA200802169A1 (ru) | Способы анализа гидроксикарбоната лантана | |
| ATE438856T1 (de) | Biomarker für eierstockkrebs: mit ctap3 verwandte proteine | |
| GB201014028D0 (en) | In-situ reagent | |
| IN2012DN03911A (ko) | ||
| WO2010014854A3 (en) | Antibodies that neutralize botulinum neurotoxins | |
| MX2010005377A (es) | Metodo para caracterizacion de proteina policlonal recombinante. | |
| PL2185937T5 (pl) | Sposób wykrywania posocznicy u ludzi | |
| WO2010075360A3 (en) | Methods for detection of sepsis | |
| WO2008112258A3 (en) | Modified proteases | |
| MX2017011195A (es) | Metodos para mejorar la captacion especifica de neurotoxinas botulinicas en las celulas. | |
| EA201171178A1 (ru) | Устройство и способ для определения и количественного анализа аналитов, в частности, микотоксинов | |
| DK2118666T3 (da) | Fremgangsmåde til normalisering af koncentrationen af analytter i en urinprøve | |
| IN2012DN01954A (ko) | ||
| WO2012164525A3 (en) | Aging biomarkers | |
| WO2012145516A3 (en) | Methods and kits for quantitative determination of total organic acid content in a coolant | |
| WO2012077139A8 (en) | Method for the diagnosis of a carcinoma and uses thereof | |
| MX2009008525A (es) | La determinacion cuantitativa de risedronato en orina mediante spe-lc-ms-ms. |